Spectrum has announced a shortage of Fusilev (levoleucovorin injection) with limited supplies continuing to be available. Fusilev is a folate analog used to reduce toxicity of high-dose methotrexate (MTX) therapy in osteosarcoma. It is also indicated to decrease the toxicity and counteract the effects of impaired MTX elimination or inadvertent overdose of folic acid antagonists.

For more information call (877) FUSILEV or visit www.fusilev.com.